# GlaxoSmithKline, LLC. – FDA Inspection, Mar 7, 2025

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/b8f525fd-c7f3-4be7-96cb-3b6521628f55
Source feed: FDA_Inspections

> FDA inspection 1274978 of GlaxoSmithKline, LLC., March 07, 2025. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1274978
- Company Name: GlaxoSmithKline, LLC.
- Inspection Date: 2025-03-07
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Philadelphia District Office
- Citation Count: 0

## Related Documents

- FDA Inspection 1332910 - 2026-07-15
- [FDA Inspection 1261906 - 2024-09-25](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/a2084345-5a0c-4a87-8363-0d2bd8669d45)
- FDA Inspection 1211050 - 2023-06-20
- [FDA Inspection 1043309 - 2018-01-26](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/0b5167aa-cc71-4870-ab00-b2a540d138b4)
- FDA Inspection 927643 - 2015-05-08

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/olumide-a-martins/e325adf8-64a0-426a-b22f-2503e41a3f5a)
- [Issuing Officer](https://www.keypedia.com/people/shadia-zaman/c534a993-7a9b-401e-bfe7-b209a916cf6e)

Company: https://www.keypedia.com/companies/glaxosmithkline-llc/7ab59069-93ea-4898-a74a-874992c27286

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8